2019 Faculty Members

Husam Abdel-Qabir, MD, PhD, FRCPC, DABIM

Assistant Professor of Medicine at the University of Toronto; scientist at Women’s College Research Institute, the Ted Rogers Centre for Heart Research, and the Institute for Clinical Evaluative Sciences; Cardiologist at Women’s College Hospital and the University Health Network

founder

Husam Abdel-Qadir graduated from medical school at the University of Toronto in Canada with the Silver Medal in 2007. He has since developed an interest in cardiovascular disease among patients with cancer and other non-cardiovascular co-morbidities. He completed a PhD in Clinical Epidemiology and Health Care Research at the University of Toronto’s Institute for Health Policy, Management, and Evaluation. At present, the primary focus of his research program is the long-term cardiovascular health of breast cancer survivors.

Conference Topic- Session 3: Practice Changing Canadian Research in Central Canada

Read More...

In recognition of his research productivity, he was awarded the 2017 European Society of Cardiology Young Investigator Award in the Clinical Sciences Category, the inaugural Young Investigator Competition at the 2017 Global Cardio-Oncology Summit and the 2018 Polanyi prize in Medicine/ Physiology.

Christine Brezden-Masley, MD, PhD, FRCPC

Associate Professor of Medicine, University of Toronto; Head, Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON, Canada. President, Canadian Cardiac Oncology Network

founder

Dr. Christine Brezden-Masley is a practicing Medical Oncologist and the Division Head of Hematology / Oncology at St. Michael’s Hospital in Toronto. She is the Co-Director of the Hematology/Oncology Clinical Research Group there. She obtained her PhD in Medical Biophysics at Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is currently an Associate Professor at the University of Toronto and an Associate Scientist at the Li Ka Shing Knowledge Institute.

Conference Topic - Session 1: Welcome and Introduction

Conference Topic - Session 4 Debate: QTc is a critical measurement in oncologic therapy (Position: NO)

Co-Chair - Session 6: Establishing a Cardio-Oncology Program

Read More...

She is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto Region. She treats both Breast and GI (colorectal and gastric cancers) malignancies and these are the major areas of her clinical research. Her main area of clinical research is cardiotoxicity from cancer therapy and has been the Co-Chair of the Annual Canadian Cardio-Oncology Network meeting, a collaborative national meeting improving cardiac heath in cancer patients. She is currently the President of the Canadian Cardio-Oncology Network. She is active in research, education and has been instrumental in the clinical development of the cancer program at St. Michael’s Hospital.

Chi-Ming Chow, MD, MSc

Professor of Medicine at the University of Toronto; Cardiologist at St. Michael’s Hospital

founder

Dr. Chi-Ming Chow is an attending staff cardiologist at St. Michael’s Hospital. He is a full professor in the Department of Medicine, University of Toronto. He has an undergraduate degree in computer science from Brown University, USA. He completed his Doctor of Medicine (1990) at McGill University (Montréal, Québec) and a Masters of Science in Epidemiology at McGill University (1997). He completed his training in Family Medicine, Internal Medicine and Cardiology at McGill University. He then pursued his clinical and research echocardiography fellowship at Massachusetts General Hospital, Harvard University before joining the Division of Cardiology at St. Michael’s Hospital in 2001.

Conference Topic- Session 2: Global Longitudinal Strain and Echocardiography

Read More...

Clinically he specializes in non-invasive cardiac imaging, in particular echocardiography and stress echocardiography. He is the Director of the Echocardiography Laboratory at St. Michael's Hospital. Currently, he a past president of the Canadian Society of Echo (CSE) and the president of the Chinese Canadian Medical Society (CCMS). His academic interests include medical informatics and he has authored many popular medical education software programs (e.g. CardioMath, ECG Made Simple, iCCS for the Canadian Cardiovascular Society, iASE Guidelines App for the American Society of Echocardiography, CDA Clinical Practice Guidelines, iSVU Guidelines for the Society for Vascular Ultrasound, and Choosing Wisely Canada). These medical software programs are being used by healthcare professionals and students worldwide. His other current areas of research include ethnic differences in cardiovascular disease and investigating new technologies in non-invasive imaging. He also works on using artificial intelligence/machine learning to improve cardiac imaging and patient care. He had won multiple local and national teaching awards to recognize his teaching and innovation in medical education. Some of his awards include the CSE achievement award in 2017, the CCS Distinguished Teacher Award in 2015, the Ruedy Award for Innovation in Medical Education presented by the Association of Faculties of Medicine of Canada and the Dalhousie University Faculty of Medicine and the 2009 William Goldie Prize for Innovation by the Department of Medicine, University of Toronto. He has authored multiple peer-reviewed journals and presented in local, national and international scientific meetings.

Margot Davis, MD SM FRCPC

Clinical Assistant Professor, University of British Columbia (UBC); Director, UBC Cardiology-Oncology Program

founder

Margot Davis is a cardiologist at Vancouver General Hospital and St. Paul’s Hospital, a Clinical Assistant Professor at the University of British Columbia, and Director of the UBC Cardiology-Oncology Program. She attended medical school and completed her Internal Medicine residency and Cardiology fellowship at the University of British Columbia. She then completed fellowships in Advanced Heart Failure & Transplant Cardiology and Cardio-Oncology & Cardiac Amyloidosis at Stanford University School of Medicine. She obtained her Master of Science degree in clinical epidemiology at the Harvard School of Public Health.

Chair - Session 2: Latest Advances in Cardiac Imaging

Conference Topic - Session 5: Clinical Applications in Cardio-Oncology in Malignant Hematology

Read More...

Her research interests are focused on the prevention, diagnosis, and management of heart disease related to cancer therapy, cardiac amyloidosis, and advanced heart failure.

Susan Dent, MD, FRCPC

Professor of Medicine, Associate Director of Breast Cancer Research and Co-Director of Cardio-Oncology, Duke University, Durham, NC, USA; Founder & Past-President, Canadian Cardiac Oncology Network

founder

Dr. Susan Dent is a Professor of Medicine, Associate Director of Breast Cancer Research and Co-Director of Cardio-Oncology at Duke University. She obtained her MD at McMaster University and completed her postgraduate training in Internal Medicine at the University of Ottawa. She continued her training in Medical Oncology in Ottawa, followed by a fellowship year in Clinical Research with the Canadian Cancer Trials Group.

Chair- Session 4: Poster Presentations and Debate

Conference Topic - Session 6: Establishing a Cardio-Oncology Program in an Academic Institution

Read More...

Her areas of research interest include breast cancer, and treatment related toxicities with a particular interest in cardiotoxicity. She is the Founder and past-president of the Cardiac Oncology Network, an organization dedicated to improving our understanding of how cancer treatments impact cardiovascular health with the ultimate goal of preventing cardiotoxicity.

Darryl Leong, MBBS (HONS), MPH, M.BIOSTAT, PHD, FRACP, FESC

Assistant Professor, Department of Medicine, McMaster University. Staff Cardiologist, Hamilton Health Sciences

founder

Dr. Leong graduated from the University of Adelaide Medical School with Deans Listing and Honours for academic excellence in 2000. He completed his cardiology training, Doctor of Philosophy, Master of Public Health, and Master of Biostatistics degrees at the University of Adelaide, Australia. He has completed a post-doctorate fellowship in cardiovascular imaging at the Leiden University Medical Centre, the Netherlands, before re-locating to Canada. He is currently a Clinician Scientist of the Heart and Stroke Foundation of Canada.

Conference Topic- Session 5: Clinical Applications in Cardio-Oncology in Prostate Cancer

Read More...

His research is supported by the Canadian Institutes of Health Research, and he has published >100 manuscripts including all the leading internal medical (NEJM, Lancet, JAMA) and cardiovascular (Circulation, Eur Heart J, J Am Coll Cardiol, Blood) journals. His h-index is 34 (Jan 2019). He leads prospective clinical cardio-oncology studies in prostate cancer, chronic myeloproliferative neoplasms, and trastuzumab cardiotoxicity in breast cancer.

Negareh Mousavi, MD

Director, Cardio-Oncology Program, McGill University Health Centre, Montreal, QC, Canada, McGill University Health Centre

founder

Dr. Negar Mousavi is an assistant professor of medicine at McGill University. Her advanced training was in multi-modality cardiovascular imaging including echocardiography, cardiac MRI, cardiac CT and nuclear cardiology. She is the director of the Cardio-Oncology program at McGill University Health Center. Her research interest is in the utility of advanced imaging techniques for detection of subclinical cancer-therapy related micro- and macrovascular disease.

Conference Topic - Session 1: Welcome and Introduction

Conference Topic - Session 4 Debate: QTc is a critical measurement in oncologic therapy (Position: YES)

Co-Chair - Session 6: Establishing a Cardio-Oncology Program

Sharon L. Mulvagh, MD, FRCPC, FACC, FASE, FAHA

Professor of Medicine, Dalhousie University; Professor Emeritus, Mayo Clinic

founder

Sharon Mulvagh MD, FRCP(C), FACC, FASE, FAHA is Professor of Medicine, Co-director of the Women’s Heart Health Clinic at the Maritime Heart Center, and Director of the Point of Care Ultrasound Internal Medicine Program, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada. She is also Professor Emeritus, Mayo Clinic, in Rochester Minnesota, where she was Past-Director of the Women’s Heart Clinic, and Associate Director of Preventive Cardiology.

Conference Topic- Session 3: Practice Changing Canadian Research in Eastern Canada

Read More...

She is a clinical investigative cardiologist recognized nationally and internationally for her research and education focused on heart disease in women, cardio-oncology, microgravity/spaceflight, noninvasive cardiovascular imaging, specifically echocardiographic imaging using new technologies including contrast echocardiography and myocardial perfusion imaging, and point of care ultrasound. Dr. Mulvagh is a fellow of the American College of Cardiology, American Heart Association, American Society of Echocardiography, and Royal College of Physicians and Surgeons of Canada. She is board certified in Internal Medicine, Cardiovascular Diseases, and Echocardiography. She has been on the Board of Directors, and chaired numerous committees for the American Society of Echocardiography, and currently serves on the Board of Directors for the International Contrast Ultrasound Society, Canadian Society of Echocardiography, Heart and Stroke Nova Scotia, and Canadian Women’s Heart Health Alliance, where she also chairs the Knowledge Translation and Mobilization Working Group. Dr. Mulvagh graduated magna cum laude with her MD from the University of Ottawa, Canada, then completed internship at Dalhousie University, residency at Boston University, and fellowship at Baylor College of Medicine, Houston, Texas. She worked at NASA, Johnson Space Center as a consultant with Universities Space Research Association prior to commencing her career at Mayo Clinic in 1990, from which she retired in 2016 and returned to Canada to pursue her clinical, education and research passions. She has well over 100 peer-reviewed manuscripts and book chapters addressing investigative frontiers in echocardiography, women and heart disease, cardio-oncology, and point of care ultrasound.

Paul Nathan, MD, MSc, FRCPC

Director, Aftercare Program and Staff Oncologist, Hospital for Sick Children, Professor of Pediatrics and Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

founder

Dr. Paul Nathan is a pediatric Hematologist/Oncologist and Director of the AfterCare clinic in the Division of Pediatric Hematology/Oncology at the Hospital for Sick Children in Toronto. He is a Professor of Pediatrics and Health Policy, Management and Evaluation at the University of Toronto, and an adjunct scientist at ICES. His research and clinical practice is focused on long-term outcomes in survivors of childhood cancer including the cardiac complications of cancer therapy.

Conference Topic- Session 1: Cardiac Risk Factors in Survivors of Childhood Cancer

Read More...

He is the principal investigator on a CIHR team grant focused on developing innovative imaging, biomarker and genetic methods for predicting risk for cardiac dysfunction in this population, and a more recent study assessing vascular structure and function in survivors. His research is funded by CIHR, the Canadian Cancer Society Research Institute, and the Ontario Institute for Cancer Research, among others.

Tomas G. Neilan, MD, MPH, MRCPI

Associate Professor of Medicine, Harvard Medical School, Director, Cardio-oncology Program, Co-Director Cardiac MR PET CT Program, Associate Director of the MGH T32 Training Program in Cardiovascular Imaging, Division of Cardiology, Massachusetts General Hospital

founder

Dr. Neilan completed his MD at University College Dublin Medical School. He completed his clinical training in Internal Medicine and Cardiology at the Mater Hospital in Dublin and at Massachusetts General Hospital. He also competed advanced training in Echocardiography at Massachusetts General Hospital, a Cardiac MRI fellowship at the Brigham and Women’s Hospital and a master of public health degree at the Harvard School of Public Health.

Conference Topic- Session 5: Clinical Applications in Cardio-Oncology as it relates to Immune Checkpoint Inhibitors

Read More...

Dr. Neilan has been awarded the “de Gunzburg Family Endowed Scholar in Cardiology”, The Locke Award for excellence in medical education and elected as a Senior Fellow to the Oliver Wendell Holmes Society at Harvard Medical School. His career has had two major focuses: 1) Understanding how we can improve the cardiovascular care of patients with cancer and 2) The use of advanced imaging to better understand and characterize cardiovascular disease among persons living with HIV.

Ian Paterson, MD, FRCPC

Cardiologist, Department of Medicine, Division of Cardiology, University of Alberta, Edmonton, AB, Canada

founder

Dr. Ian Paterson is a Professor of Medicine in the Division of Cardiology at the University of Alberta. He completed his Cardiology training and an Echocardiography Fellowship at the McGill University, followed by a Cardiovascular MRI Fellowship at the National Institutes of Health. He is the Academic and Research Director of Cardiovascular Magnetic Resonance at the University of Alberta and Past President of the Canadian Society of Cardiovascular Magnetic Resonance.

Chair- Session 1: Plenary Lecture and Considerations for Special Populations

Conference Topic- Session 3: Practice Changing Canadian Research on the West Coast

Read More...

Cardiologist, Department of Medicine, Division of Cardiology, University of Alberta, Edmonton, AB, Canada

Rod Rassekh, MD, MHSc

Pediatric Oncologist, BC Children's Hospital; Clinician-Investigator, Michael Cuccione Childhood Cancer Research Program; Clinical Assistant Professor, University of British Columbia

founder

Rod Rassekh grew up in Vancouver, and then went east to McGill to study Microbiology & Immunology. He returned home for medical school and graduated from UBC in 2000. He completed his pediatric residency and continued on to complete his Pediatric Hematology/Oncology fellowship in 2007, both at BC Children's Hospital. He also obtained a Masters of Health Science from UBC in 2007. Since completing his training he has been a Clinical Assistant Professor at BCCH, and a clinician-investigator in the Michael Cuccione Childhood Cancer Research Program at BCCH Research Institute.

Conference Topic- Session 2: Genetic Predictors of Long Term Cardiotoxicity Following Anthracycline Therapy

Read More...

His research interests are in bringing genomics into the oncology clinics, with a special focus on Pharmacogenetics of drug toxicity and tumor genomics to guide therapy. As the oncology lead on the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), he has helped discover genes associate with cardiac toxicity due to anthracyclines and the development and use of risk prediction models for children who need this chemotherapeutic agent.

Jessica Scott, PhD

Assistant Member, Exercise Oncology Service at Memorial Sloan Kettering Cancer Center

founder

Jessica Scott, PhD, is an Assistant Member in the Exercise Oncology Service at Memorial Sloan Kettering Cancer Center. She received her PhD in Exercise Cardiovascular Physiology at the University of British Columbia in Vancouver, Canada, and completed her Post-doctoral Fellowship at NASA Johnson Space Center (JSC) in Houston, Texas. She joined MSK in 2017 after 5 years as a Senior Scientist in the Exercise Physiology and Countermeasures Laboratory at JSC. Her research is focused on: (1) characterization of cancer treatment-related multisystem toxicity using exercise testing, imaging, and biomarker techniques, and (2) the efficacy of exercise training to prevent and/or reverse toxicity.

Plenary Lecture- Session 1: Optimizing Cardiac Health in Cancer Patients through Exercise

Christine Simmons, MD

Medical Oncologist, BC Cancer Agency Vancouver; Clinical Associate Professor, Department of Medicine, University of British Columbia, Vancouver, BC, Canada

founder

Dr. Christine Simmons is a Medical Oncologist at the BCCA Vancouver and Clinical Associate Professor in the Department of Medicine at the University of British Columbia. She completed her residency training in Toronto, and completed a fellowship at Princess Margaret Hospital in Toronto. She also completed a Master’s in Clinical Epidemiology at University of Toronto. She is currently the Chair of Sarcoma Systemic Program for BCCA.

Chair - Session 5: Clinical Applications in Cardio-Oncology

Read More...

She is the former chair of the Locally Advanced Breast Cancer National Consensus group and still plays a key role in that organization. Her academic interests span both teaching and research, and she has held several leadership roles in the Undergraduate Medical Program at UBC in the areas of clinical skills and oncology education. Her research interests are in the areas of health services research in breast cancer and sarcoma. She recently founded the Sarcoma Outcomes Unit at the BC Cancer Agency, and is Founder and Chair of the not‑for‑profit organization, Women in Cancer.

Dinesh Thavendiranathan, MD, MSc SM, FRCPC, FASE

Director, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, Associate Professor of Medicine; University of Toronto, Toronto, ON, Canada

founder

Dr. Paaladinesh Thavendiranathan MD, MSc SM, FRCPC, FASE is a cardiologist at the Toronto General Hospital, University of Toronto. He is an Associate Professor of Medicine and a Clinician Investigator. His training was in advanced cardiovascular imaging and his current clinical practice involves work with cardiac MRI, CT, and echocardiography.

Chair - Session 3: Practice Changing Canadian Research

Read More...

He is the Director of the Ted Rogers Program in Cardiotoxicity Prevention which focuses on cardiac toxicity from systemic therapies including cancer therapy. His research focus is in the use of advanced cardiac imaging techniques for detection and management of cardiac toxicity.

Camilla Wong, MD FRCPC MHSc

Geriatrician, St. Michael’s Hospital; Associate Professor, University of Toronto; Project Investigator, Li Ka Shing Research Institute, St. Michael's Hospital

founder

Dr. Camilla Wong is a geriatrician at St. Michael's Hospital, associate professor at the University of Toronto, and project investigator at the Li Ka Shing Knowledge Institute. Her clinical and research interests include 'interface geriatrics' -- the intersection between proactive comprehensive geriatric assessment and a health event that results in a significant change in the health status of an older adult. Her publications have appeared in JAMA, CMAJ, and the Annals of Surgery.  

Conference Topic- Session 1: Cardiovascular Dysfunction in the Older Adult Patient Population

Kibar Yared, MD

Director, Cardiac Imaging; Director, Cardio-Oncology Program; Scarborough Health Network, Toronto, ON

founder

Dr. Yared is currently Director of Cardiac Imaging at The Scarborough Health Network. He is also the Medical Director of the Cardio-Oncology clinic. Before moving to Toronto, Dr. Yared received his medical degree as well as Cardiology training at McGill University in Montreal. He subsequently completed an advanced Cardiac Imaging fellowship at the Massachusetts General Hospital – Harvard Medical School in Boston, Massachusetts. In Toronto, he was responsible for introducing advanced imaging techniques in Echocardiography and Cardiac MRI. He has also spearheaded a Cardio-Oncology clinic which actively follows upwards of 450 patients.

Conference Topic- Session 6: Establishing a Cardio-Oncology Program at a Community Hospital

Tallal Younis, MBBCh, FACP, FRCP (UK)

Professor of Medicine, Dalhousie University. Medical Oncologist, Queen Elizabeth II Health Sciences Centre. Co-chair, Nova Scotia Breast Cancer Site Team

founder

Dr Younis is a professor of medicine at Dalhousie University, and a consultant medical oncologist at the Queen Elizabeth II Health Sciences Centre (QE II HSC) in Canada. He received his medical degree from Cairo University in 1992 and an MRCP degree from the United Kingdom in 1998. He completed an internal medicine residency in 2001 at the Columbia University and a medical oncology fellowship in 2003 at the Roswell Park Cancer Institute in the USA.

Conference Topic- Session 5: Clinical Applications in Cardio-Oncology for Breast Cancer: A Focus on HER2 Targeted Therapies

Read More...

Dr Younis clinical practice is devoted to breast cancer, and he is board certified (ABIM) in internal medicine and medical oncology. He is the research director for medical oncology at the QEII HSC, and an editor for “Current Oncology” journal. His research interests involve health services research and health technology assessments in breast cancer.